MCS Medical Compression Systems (DBN) Ltd. (TASE:MDCL) yesterday published a shelf prospectus for an undisclosed amount. The maker of non-invasive compression systems to prevent blood clots in the limbs, has a market of NIS 26 million, compared with NIS 60.5 million when it held its IPO in mid-2006.
The filing of a shelf prospectus does not commit a company to actually raise capital, but gives it the option to do so. MCS declined to respond or state its intensions.
In contrast to the previous quarter, when many TASE-listed companies published shelf prospectuses, MCS is so far the only company that has done this quarter.
The company has published a number of positive announcements recently, but its timing has been terrible. In June, it completed the clinical trial for its product, which showed that the product was effective in preventing deep vein thrombosis without the need for accompanying medication.
Published by Globes [online], Israel business news - www.globes-online.com - on November 6, 2008
© Copyright of Globes Publisher Itonut (1983) Ltd. 2008